For more information, contact
Tom Gardner (317) 841-8014 x101
tom.gardner@RNDGroup.com
The RND Group is selected by GeneNews to design, implement, and test the software for the GeneNews ColonSentry™ Product
March 28, 2007 - INDIANAPOLIS, IN – GeneNews Limited (TSX:GEN), formerly ChondroGene Limited, has selected the RND Group, Inc. to design, implement, and test the software for the GeneNews ColonSentry™ product, a blood-based test to detect colon cancer. The ColonSentry™ test is a quantitative in vitro diagnostic test intended to measure the relative expression of a panel of mRNA species, isolated from whole human blood. "After evaluating different options, we decided to engage the RND Group because of their reputation, experience and the positive comments from past customers," stated Bruno Maruzzo, Director, Corporate Development at GeneNews Limited.
RND brings its extensive experience developing custom software for FDA regulated products to help GeneNews design, implement and test this software. “This project is the perfect fit for RND because it is full lifecycle, is in line with all the other Molecular projects we are doing, and leverages our experience successfully delivering C# solutions for the medical device industry”, stated Tim DeFrench, CEO, The RND Group, Inc.
For more information on the RND Group, contact RND at 1-317-841-8070 or via email at info@RNDGroup.com.
About GeneNews
GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel PrincipleTM, to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle TM in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews’ first product in development, ColonSentry, is a blood-based test that can detect colon cancer. For more information on GeneNews, visit www.genenews.com
About the RND Group
The RND Group provides full life cycle software engineering services specializing in medical device and consumer electronic product development. We work with companies by partnering with their product development organizations in providing project management, requirements management, software engineering, and product testing services as needed to complement our clients’ existing engineering departments. For more information on the RND Group, visit www.RNDGroup.com
RND is proud to be celebrating ten years of providing quality software engineering services to our customers.
### |
